EB

Elisabetta Bianchi

Merck: 5 patents #18 of 712Top 3%
RP Ra Pharmaceuticals: 2 patents #2 of 36Top 6%
A( Assistance Publique—Hôpitaux De Paris (Aphp): 1 patents #8 of 173Top 5%
IP Institut Pasteur: 1 patents #2 of 71Top 3%
UC Université Paris Cité: 1 patents #5 of 111Top 5%
Overall (2022): #23,303 of 548,613Top 5%
6
Patents 2022

Issued Patents 2022

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
11530244 Cyclic polypeptides for PCSK9 inhibition Alonso Ricardo, Thomas J. Tucker, Nicolas Cedric Boyer, Joseph R. Stringer, Derek M. LaPlaca +15 more 2022-12-20
11505575 Cyclic polypeptides for PCSK9 inhibition Alonso Ricardo, Thomas J. Tucker, Nicolas Cedric Boyer, Ketki Ashok Dhamnaskar, Zhong Ma +9 more 2022-11-22
11492385 Long-acting co-agonists of the glucagon and GLP-1 receptors Anandan Palani, Ravi Nargund, Paul E. Carrington, Tomi K. Sawyer, Qiaolin Deng +2 more 2022-11-08
11427616 PCSK9 antagonist compounds Harold B. Wood, Hubert Josien, Thomas J. Tucker, Angela Dawn Kerekes, Ling Tong +9 more 2022-08-30
11306125 PCSK9 antagonists bicyclo-compounds Yusheng Xiong, Thomas J. Tucker, Chengwei Wu, Danila Branca, Angela Dawn Kerekes +6 more 2022-04-19
11249090 Immunological signatures and parameters predicting therapeutic responses to anti-TNF therapy LARS ROGGE, Silvia Menegatti, MAXIME DOUGADOS 2022-02-15